arbekacin and beta-lactams

arbekacin has been researched along with beta-lactams in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hanaki, H; Matui, H; Oishi, T; Sunakawa, K; Uehara, K; Yamaguchi, Y; Yanagisawa, C	1
Hagane, K; Hanaki, H; Hashimoto, T; Ikeda-Dantsuji, Y; Ishizaki, A; Kageyama, Y; Kawaguchi, T; Kawajiri, H; Ono, T; Sato, S; Sugahara, K; Sunakawa, K; Tachihara-Sato, R; Takahashi, Y; Tamura, A; Yamaguchi, Y; Yanagisawa, C; Yanagisawa, T; Yazaki, H	1
Akashi, K; Chong, Y; Harada, Y; Kadowaki, M; Miyake, N; Shimoda, S; Shimono, N; Uchida, Y	1
Hatta, Y; Hirabayashi, Y; Hojo, A; Iriyama, N; Kobayashi, S; Kobayashi, Y; Kodaira, H; Kurita, D; Kusuda, M; Miura, K; Nakagawa, M; Ohtake, S; Sakagami, M; Takahashi, H; Takei, M; Uchino, Y	1

Trials

1 trial(s) available for arbekacin and beta-lactams

Article	Year
Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies. International journal of hematology, 2016, Volume: 103, Issue:3 Topics: Adult; Aged; Anti-Infective Agents; beta-Lactams; Dibekacin; Drug Monitoring; Drug Therapy, Combination; Febrile Neutropenia; Female; Fluoroquinolones; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Treatment Outcome	2016

Article

Year

Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies.

International journal of hematology, 2016, Volume: 103, Issue:3

Topics: Adult; Aged; Anti-Infective Agents; beta-Lactams; Dibekacin; Drug Monitoring; Drug Therapy, Combination; Febrile Neutropenia; Female; Fluoroquinolones; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Treatment Outcome

2016

Other Studies

3 other study(ies) available for arbekacin and beta-lactams

Article	Year
[Combination effect of pazufloxacin and anti-mrsa drugs against beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR)]. The Japanese journal of antibiotics, 2005, Volume: 58, Issue:1 Topics: Aminoglycosides; beta-Lactams; Dibekacin; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; In Vitro Techniques; Methicillin Resistance; Minocycline; Oxazines; Staphylococcus aureus; Teicoplanin; Vancomycin Resistance	2005
Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:5 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Time Factors; Vancomycin; Vancomycin Resistance	2009
Nosocomial spread of meticillin-resistant Staphylococcus aureus with β-lactam-inducible arbekacin resistance. Journal of medical microbiology, 2014, Volume: 63, Issue:Pt 5 Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Dibekacin; DNA Transposable Elements; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Japan; Methicillin-Resistant Staphylococcus aureus; Molecular Sequence Data; Molecular Typing; Sequence Analysis, DNA; Staphylococcal Infections; Transcriptional Activation	2014